开盘$14.43
昨收$14.53
当日区间$14.35 – $14.91
成交量2.64M
市值$12.43B
市盈率（TTM）42.0
股息率0.56%
RDY 相关新闻
匹配 Dr. Reddy's Laboratories 或代码 RDY 的头条新闻，按最新排序。
- Published on 09/30: RDY Shows Double Bottom, as Citi Upgrades Dr. Reddy's to Buy With Target Raised to 1,450 Rupees 正面
- Citigroup Upgrades Dr Reddy's Laboratories to Buy, Raises Price Target to $1450 正面
- Morgans Sticks to Its Buy Rating for ReadyTech Holdings Ltd. (RDY)
- Jarden Remains a Buy on ReadyTech Holdings Ltd. (RDY)
- Shaw and Partners Keeps Their Buy Rating on ReadyTech Holdings Ltd. (RDY)
- Elara Securities India Downgrades Dr. Reddy's Laboratories to Reduce From Accumulate; Price Target Is INR1,283 负面
- Nomura Adjusts Dr. Reddy's Laboratories' Price Target to INR1,740 From INR1,600, Keeps at Buy
- Shaw and Partners Reaffirms Their Buy Rating on ReadyTech Holdings Ltd. (RDY)
- BofA Securities Maintains Dr. Reddy's Laboratories(RDY.US) With Buy Rating, Cuts Target Price to $16.33 负面
- Morgans Sticks to Their Buy Rating for ReadyTech Holdings Ltd. (RDY)
- Ord Minnett Keeps Their Buy Rating on ReadyTech Holdings Ltd. (RDY)
- Ord Minnett Sticks to Its Buy Rating for ReadyTech Holdings Ltd. (RDY)
- ReadyTech Holdings Ltd. (RDY) Receives a Buy From Shaw and Partners
- Dr. Reddy's Laboratories | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
- Dr. Reddy's Laboratories | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
暂无评论——快来第一个聊聊 RDY。
登录后参与讨论。